Insider Title Company Date Price Return Shares Value
Bellini Roberto Non-Executive Director Inhibikase Therapeutics, Inc. (IKT) 2024-10-21 $1.37 0.0% 1,460,000 $2,000,200
Return Profit / (loss) Cost
Total 0.0% $0 $2,000,200